Giving Time Its Meaning: The Humble Dandelion Carries the Great Dream of Rural Revitalization
Amid the hundred-acre fields of Nanniwan Town, Yan'an City, Shaanxi Province, clusters of dandelions sway in the breeze. Behind the sea of green lies JumpCan Pharmaceutical's long-term strategic deployment to address the challenge of sourcing raw materials for TCM and contribute to rural...
First release! New breakthrough of Chinese original research innovative drug Zelimei (Benvitimod Cream)
From June 11 to 14, The 31st Annual Meeting of Chinese Society of Dermatology was held in a grand ceremony at the Capital International Exhibition & Convention Center. During the conference, the results of the first Phase III clinical trial of Zelimei (Benvitimod Cream) — an innovative drug...
JumpCan Pharmaceutical's Minfeile Selected for the Jiangsu Province Clinical Advantage Drug Catalog (First Batch)
The Jiangsu Province Clinical Advantage Drug Catalog (First Batch) (hereinafter referred to as "the Catalog") has recently been officially announced. JumpCan Pharmaceutical's product Minfeile (Fexofenadine Hydrochloride for Suspension) has been successfully selected for inclusion...
Anti-Influenza Class 1 Innovative Drug Jikeshu Approved for Adolescent Indication
On June 8, Jikeshu (INN: Sebaloxavir Marboxil Tablets), a Class 1 innovative anti-influenza drug developed through a strategic collaboration between JumpCan Pharmaceutical and Zenshine Pharmaceuticals, received official approval from the National Medical Products Administration (NMPA)...
World Environment Day: Rooting Downward, Growing Upward
JumpCan has long pursued a development philosophy of environmental stewardship and resource efficiency, treating environmental management as a "lifeline" that stands shoulder to shoulder with workplace safety and quality management. Sustainability isn't an add-on; we build it into every...
Recently, the Symposium on Healthy China and Biomedical Engineering Innovation and the 5th High-Quality TCM Development Conference were grandly held in Tianjin. At the conference, JumpCan Pharmaceutical was awarded the title of "Thirty-Year Demonstration Unit of TCM Modernization," and...
Great News! JumpCan Pharmaceutical's Pudilan Xiaoyan Oral Liquid Approved as a Protected TCM Variety
On May 15, the National Medical Products Administration approved JumpCan Pharmaceutical's exclusive dosage form product, Pudilan Xiaoyan Oral Liquid, as the first Secondary Protected TCM variety. This achievement not only represents full affirmation of the product's clinical value, quality...
From April 12 to 16, the 2026 Wuzhen Health Conference and the 5th China OTC Conference were grandly held. To promote Chinese pharmaceutical health brand building, enhance the social image and influence of Chinese pharmaceutical health brands, and drive the optimization and upgrading...
Twin Stars Shine! JumpCan Pharmaceutical's Innovative Achievements Take Center Stage at the 2026 Xiding Conference
Recently, the 2026 Xiding Conference was grandly held. As one of China's most influential annual events in the health industry, this edition gathered thousands of national chain terminals, industry elites, and industry partners to discuss industry trends. JumpCan Pharmaceutical showcased two...
Outstanding Achievement! JumpCan's Pudilan Xiaoyan Oral Liquid & Tonpei Both Make the List
From March 24 to 29, the 11st Health Industry Ecological Platform (PHCF) was grandly held in Huzhou, Zhejiang Province. The conference brought together tens of thousands of industry professionals who witnessed the announcement of multiple authoritative industry awards. Among them...